Claudia L. Kleinman

Citado por

	Total	Desde 2019
Citas	4753	3885
Índice h	36	32
Índice i10	59	56

840

420

210

630

20102011201220132014201520162017201820192020202120222023202413 30 57 88 108 127 100 137 155 292 542 649 723 831 835

Acceso público

Ver todo

72 artículos

6 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Nada JabadoMcGill Univ.Dirección de correo verificada de mcgill.ca
Nicolas De JayDirección de correo verificada de pinkfilter.org
Jacek MajewskiProfessor of Human Genetics, McGill UniversityDirección de correo verificada de mcgill.ca
Morag ParkProfessor of Oncology and Biochemistry, McGill University, Director Goodman Cancer Research CentreDirección de correo verificada de mcgill.ca
Santiago CostantinoUniversy of MontrealDirección de correo verificada de umontreal.ca
Stéphane RichardProfessor, Lady Davis Institute - McGill UniversityDirección de correo verificada de mcgill.ca
Nicolas RodrigueProfessor, Carleton UniversityDirección de correo verificada de carleton.ca
nicolas lartillotResearch Director, Université de Lyon 1Dirección de correo verificada de univ-lyon1.fr
Hervé PhilippeUniversité de MontréalDirección de correo verificada de umontreal.ca
Hamid NikbakhtAssociate Director, Advanced Analytics, Oncology EMU, GlaxoSmithKline (GSK)Dirección de correo verificada de gsk.com
Paul SavageGeneral Surgery Resident, University of TorontoDirección de correo verificada de mail.utoronto.ca
Benoit CoulombeInstitut de Recherches Cliniques de Montréal, Université de MontréalDirección de correo verificada de ircm.qc.ca
Ryuhjin AhnMassachusetts Institute of TechnologyDirección de correo verificada de mit.edu
eric shoubridgeProfessor, Human Genetics, McGill UniversityDirección de correo verificada de ericpc.mni.mcgill.ca
Kevin HaHead of Data Science, Genomics, BioSymetricsDirección de correo verificada de biosymetrics.com
Emilie LalondeLondon Health Sciences Center and Western UniversityDirección de correo verificada de lhsc.on.ca
Alessandro MichienziUniversità di Roma "Tor Vergata"-Dipartimento di Biomedicina e PrevenzioneDirección de correo verificada de uniroma2.it
Javier SantosFacultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires. iB3. CONICETDirección de correo verificada de fbmc.fcen.uba.ar

Seguir

Claudia L. Kleinman

McGill University

Dirección de correo verificada de mcgill.ca


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
Childhood cerebellar tumours mirror conserved fetal transcriptional programs MC Vladoiu, I El-Hamamy, LK Donovan, H Farooq, BL Holgado, ... Nature 572 (7767), 67-73, 2019	405	2019
H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis AS Harutyunyan, B Krug, H Chen, S Papillon-Cavanagh, M Zeinieh, ... Nature communications 10 (1), 1262, 2019	303	2019
H3. 3K27M cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas M Pathania, N De Jay, N Maestro, AS Harutyunyan, J Nitarska, ... Cancer cell 32 (5), 684-700. e9, 2017	259	2017
Comment on “Widespread RNA and DNA Sequence Differences in the Human Transcriptome” CL Kleinman, J Majewski Science 335, 1302-c, 2012	250*	2012
Stalled developmental programs at the root of pediatric brain tumors S Jessa, A Blanchet-Cohen, B Krug, M Vladoiu, M Coutelier, D Faury, ... Nature genetics 51 (12), 1702-1713, 2019	232	2019
Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR CL Kleinman, N Gerges, S Papillon-Cavanagh, P Sin-Chan, ... Nature genetics 46 (1), 39-44, 2014	223	2014
Pervasive H3K27 acetylation leads to ERV expression and a therapeutic vulnerability in H3K27M gliomas B Krug, N De Jay, AS Harutyunyan, S Deshmukh, DM Marchione, ... Cancer cell 35 (5), 782-797. e8, 2019	193	2019
Polyadenylation-dependent control of long noncoding RNA expression by the poly (A)-binding protein nuclear 1 YB Beaulieu, CL Kleinman, AM Landry-Voyer, J Majewski, F Bachand PLoS genetics 8 (11), e1003078, 2012	179	2012
A pseudouridine synthase module is essential for mitochondrial protein synthesis and cell viability H Antonicka, K Choquet, ZY Lin, AC Gingras, CL Kleinman, ... EMBO reports 18 (1), 28-38, 2017	164	2017
RNA sequencing reveals the role of splicing polymorphisms in regulating human gene expression E Lalonde, KCH Ha, Z Wang, A Bemmo, CL Kleinman, T Kwan, ... Genome research 21 (4), 545-554, 2011	156	2011
Macrocyclic lactone resistance in Dirofilaria immitis: failure of heartworm preventives and investigation of genetic markers for resistance C Bourguinat, ACY Lee, R Lizundia, BL Blagburn, JL Liotta, MS Kraus, ... Veterinary parasitology 210 (3-4), 167-178, 2015	150	2015
Histone H3. 3G34-mutant interneuron progenitors co-opt PDGFRA for gliomagenesis CCL Chen, S Deshmukh, S Jessa, D Hadjadj, V Lisi, AF Andrade, D Faury, ... Cell 183 (6), 1617-1633. e22, 2020	139	2020
Failure of human rhombic lip differentiation underlies medulloblastoma formation LD Hendrikse, P Haldipur, O Saulnier, J Millman, AH Sjoboen, ... Nature 609 (7929), 1021-1028, 2022	106	2022
Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas A Khan, LD Gamble, DH Upton, C Ung, DMT Yu, A Ehteda, R Pandher, ... Nature communications 12 (1), 971, 2021	94	2021
A C19MC-LIN28A-MYCN oncogenic circuit driven by hijacked super-enhancers is a distinct therapeutic vulnerability in ETMRs: a lethal brain tumor P Sin-Chan, I Mumal, T Suwal, B Ho, X Fan, I Singh, Y Du, M Lu, N Patel, ... Cancer cell 36 (1), 51-67. e7, 2019	89	2019
A targetable EGFR-dependent tumor-initiating program in breast cancer P Savage, A Blanchet-Cohen, T Revil, D Badescu, SMI Saleh, YC Wang, ... Cell reports 21 (5), 1140-1149, 2017	82	2017
TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw CC Gomes, T Gayden, A Bajic, OF Harraz, J Pratt, H Nikbakht, E Bareke, ... Nature communications 9 (1), 4572, 2018	81	2018
PRMT5 is essential for B cell development and germinal center dynamics LC Litzler, A Zahn, AP Meli, S Hébert, AM Patenaude, SP Methot, ... Nature communications 10 (1), 22, 2019	80	2019
ZFTA–RELA dictates oncogenic transcriptional programs to drive aggressive supratentorial ependymoma A Arabzade, Y Zhao, S Varadharajan, HC Chen, S Jessa, B Rivas, ... Cancer discovery 11 (9), 2200-2215, 2021	71	2021
SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors T Shorstova, M Marques, J Su, J Johnston, CL Kleinman, N Hamel, ... Cancer research 79 (10), 2761-2774, 2019	70	2019

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores